Best Hospitals for Penile Cancer Treatment in Bengaluru, India

Penile cancer is a rare malignancy — accounting for less than 1% of male cancers in high-income countries but rising to 1–2% in parts of South Asia, Africa, and South America — in which squamous cell carcinoma (SCC) represents over 95% of histological subtypes. SCC of the penis arises most commonly from the glans, prepuce (foreskin), or coronal sulcus, and is strongly associated with high-risk human papillomavirus (HPV) subtypes 16 and 18, phimosis, chronic inflammatory conditions such as lichen sclerosus (balanitis xerotica obliterans), and tobacco use. Less common histological variants include verrucous carcinoma, basaloid carcinoma, warty carcinoma, and rare sarcomatoid subtypes, each carrying distinct prognoses and treatment implications.

• ELIGIBLE PATIENTS:
• Histologically confirmed penile squamous cell carcinoma (or variant histology) at any stage (Tis through T4), including recurrent disease after prior treatment
• Patients with high-grade penile intraepithelial neoplasia (PeIN) unresponsive to topical therapy (imiquimod, 5-fluorouracil) or laser ablation
• Locally advanced disease (T3–T4) requiring neoadjuvant chemotherapy followed by surgery, or definitive chemoradiation
• Patients with clinically palpable inguinal lymphadenopathy (cN1–cN2) requiring inguinal lymph node dissection (ILND)
• +18 more

ORGAN-SPARING / PENILE-PRESERVING SURGERY (Preferred for T1a–T2, selected T2 lesions):

• Wide Local Excision (WLE): Surgical excision of the primary tumor with a histologically confirmed 5 mm clear margin, used for small glans or prepuce lesions. Intraoperative frozen section margin assessment is mandatory at accredited centers to minimize re-excision rates.
• Laser Ablation (CO2 or Nd:YAG): For Tis and T1a, grade 1–2 lesions where histological confirmation of non-invasive disease is established. Recurrence rates are higher (15–25%) than with WLE but functional outcomes are superior; appropriate patient selection is critical.
• Glansectomy with Split-Thickness Skin Graft (STSG) Reconstruction: The oncological standard for T1b–T2 glans-confined tumors. The entire glans is resected and the neoglans is reconstructed using a split-thickness graft (commonly harvested from the thigh). Functional and cosmetic outcomes are generally excellent; sensation is partially preserved in most patients.
• Mohs Micrographic Surgery: Specialized technique used in select centers for small, well-defined penile SCC where maximal tissue conservation is required; provides real-time margin assessment layer by layer. Available at designated dermatological oncology centers within GAF Healthcare's India and UAE network.

PARTIAL OR TOTAL PENECTOMY (T2 with corporal invasion, T3–T4):

• Partial Penectomy: Resection of the distal penis with a 5–10 mm surgical margin while preserving sufficient shaft length for upright micturition (ideally >3 cm residual length). Perineal urethrostomy is created if residual length is insufficient.
• Total Penectomy with Perineal Urethrostomy: Required for T3 (urethral/corpus cavernosum involvement) or tumors where partial resection cannot achieve clear margins. Radical penectomy may include en-bloc resection of the scrotum and pubic symphysis in T4 disease.
• Phalloplasty / Penile Reconstruction: Radial forearm free flap (RFFF) phalloplasty or anterolateral thigh (ALT) flap reconstruction is offered to selected patients post-total penectomy in specialized reconstructive urology units within the GAF Healthcare network in India and the UAE.

PHASE 1 — PRE-TRAVEL CONSULTATION (Weeks 1–2, Remote):

• Patient submits biopsy pathology reports, MRI/CT/PET imaging, and blood work to GAF Healthcare's case management team.
• Senior urological oncologist at the partner hospital reviews records and provides a written second opinion, treatment plan, and itemized cost estimate within 48–72 hours.
• GAF Healthcare assists with e-Medical Visa application (India) or UAE entry arrangements; typical e-Medical Visa processing: 3–5 business days.
• Pre-travel cardiac and anesthetic risk clearance arranged remotely if required.

PHASE 2 — ARRIVAL AND PRE-OPERATIVE WORKUP (Days 1–3 in Country):